Abcuro Presents Results from Phase 2/3 MUSCLE Study of Ulviprubart in Patients with Inclusion Body Myositis at GCOM 2026
While not reaching statistical significance, there was a slowing of disease progression relative to placebo, as measured by IBMFRS, in the overall patient population at the lower dose of ulviprubart.
Rare Rattlesnake Bite Death Reported in Orange County
Incident highlights increased snake activity on SoCal trails earlier in season
Costa Mesa Eagle Scout Dies After Rattlesnake Bite
Family seeks independent autopsy after 25-year-old's tragic death on Irvine trail